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Home use of urine pregnancy tests for medical abortion 
follow-up
In The Lancet Global Health, Kirti Iyengar and colleagues1 
report ﬁ ndings from a randomised, controlled, non-
inferiority trial in 731 women, which compared the 
eﬀ ectiveness of standard clinic follow-up after medical 
abortion versus self-assessment with use of a low-
sensitivity urine pregnancy test at home. The primary 
outcome was eﬃ  cacy of the abortion procedure, 
deﬁ ned as complete abortion without the need for 
additional clinical intervention within 30 days of 
study enrolment. The ﬁ ndings showed no signiﬁ cant 
diﬀ erences between the two study groups: 95% of 
women in the home-assessment group reported having 
a complete abortion compared with 93% of women in 
the clinic follow-up group.
This study addresses an important question about 
whether routine clinic follow-up after medical abortion 
can be responsively eliminated from service delivery 
protocols, thus reducing a key barrier to accessing 
medical abortion. Such a service change could be 
especially beneﬁ cial for women in rural, low-resource 
settings such as Rajasthan, India, where the study was 
done. The ﬁ ndings also underscore the high eﬃ  cacy 
and safety of early medical abortion with a regimen 
of 200 mg mifepristone followed by misoprostol,2 
thus conﬁ rming that most women do not need clinic 
follow-up.
Yet the investigators’ main conclusion—that self-
assessment of medical abortion at home with use of a 
low-sensitivity pregnancy test is as eﬀ ective as clinic-
based follow-up—seems premature, especially given 
that the primary outcome used in this study was eﬃ  cacy 
of the abortion procedure. From a clinical perspective, 
the most important reason for using urine pregnancy 
tests after medical abortion is to identify possible 
cases of ongoing pregnancy that might otherwise go 
undetected in the short-term in absence of routine clinic 
follow-up. In recognition of this, several other studies on 
the same topic is detection of continuing pregnancy as 
the primary outcome,3–8 which is arguably the outcome 
of greatest importance in medical abortion follow-up 
given the need for its rapid and accurate recognition. 
In the study by Iyengar and colleagues, ﬁ ve continuing 
pregnancies were identiﬁ ed in the clinic follow-up 
group compared with two in the home-assessment 
group. Although these diﬀ erences were not statistically 
signiﬁ cant, we cannot know for certain if some 
continuing pregnancies in the home-assessment group 
went undetected because of either human or test error, 
since most outcomes in this group were determined 
through the woman’s self-report of her test results. 
Furthermore, since the study was primarily concerned 
with overall eﬀ ectiveness of the abortion procedure, it 
was not powered to detect diﬀ erences in incidence of 
ongoing pregnancy.
Iyengar and colleagues are not the only researchers 
stymied by the practical and methodological 
complexities of assessing home follow-up after medical 
abortion. A study by Oppegaard and colleagues9 that 
compared standard clinic follow-up versus home 
assessment with a semi-quantitative pregnancy test 
also selected the eﬀ ectiveness of the abortion procedure 
as the primary outcome. In this study of 924 women 
in four European countries, complete abortion was 
reported to be 94% in women in the self-assessment 
group compared with 95% in the clinic follow-up group. 
These results led to a ﬁ nding of non-inferiority despite 
the fact that none of three continuing pregnancies in 
the self-assessment group were detected by the test. 
In the study by Iyengar and colleagues no additional 
continuing pregnancies were subsequently identiﬁ ed 
after women had exited the study. However, this 
outcome could have been a result of challenges in 
maintaining contact with study participants in the rural, 
low-literacy setting in which this study was done. Yet 
both studies aﬃ  rm the safety of home assessment after 
medical abortion. In both cases, the incidence of adverse 
events such as haemorrhage, infection, or hospital 
admission was not any higher in women with home 
follow-up than in those with routine clinic follow-up.
The discrepancy in primary outcomes used to 
investigate home assessment with urine pregnancy tests 
after medical abortion ultimately raises the question of 
what information is most essential—both for research 
and clinical purposes. Although the detection of 
continuing pregnancy is a crucial outcome that requires 
additional clinical intervention and could otherwise go 
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undetected in the short term, perhaps assurance that all 
continuing pregnancies will always be detected through 
home use of urine pregnancy tests is not an essential 
prerequisite for elimination of the routine follow-
up visit, or for the provision of high-quality medical 
abortion care. Indeed, all continuing pregnancies will 
eventually be detected and most pose no health risks to 
women in the meantime. The WHO has already come to 
this conclusion in its most recent abortion guidelines,10 
which stipulate that routine clinical follow-up is not 
needed after medical abortion, and that repeat hCG 
testing can be used to conﬁ rm a complete outcome. 
Maybe it is time to go one step further by removing 
routine follow-up requirements of any sort from 
medical abortion service delivery protocols, bolstered in 
part by knowledge from studies, such as that by Iyengar 
and colleagues, which conﬁ rm the eﬀ ectiveness of the 
medical abortion procedure and the ability of women to 
safely determine themselves when and if clinic follow-
up is needed.
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